Triple agonists are synthetic peptide molecules engineered to bind and activate three distinct G-protein-coupled receptors simultaneously: the GLP-1 receptor (GLP-1R), the GIP receptor (GIPR), and the glucagon receptor (GCGR)
This study was stopped early due to the clear efficacy of the treatment, highlighting its role in preventing the progression to end-stage renal failure
Vitamin C supplementation in pregnancy
Effect of trans resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function
Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia
Compounded Options: Local and national pharmacies continue to provide lower-cost alternatives, though recent semaglutide news highlights a major FDA crackdown on "mass-marketed" copycat versions to ensure patient safety